Treatment

JNJ-95804306 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
This study is testing a new medicine, JNJ-95804306, for people with certain blood cancers like acute myeloid leukemia (AML) or chronic lymphocytic leukemia (CLL) that have come back or not responded to previous treatments. It aims to find a safe dose and see how well it works.
For: Hematologic Neoplasms
United States · Australia · Belgium